RT Boosts Immunotherapy in NSCLC – MedPage Today
|
RT Boosts Immunotherapy in NSCLC
MedPage Today Patients with advanced non-small cell lung cancer (NSCLC) lived significantly longer without disease progression if they received radiation therapy prior to starting immunotherapy, a retrospective review showed. Median progression-free survival (PFS) … |
